Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-15-009092
Filing Date
2015-11-25
Accepted
2015-11-25 11:57:37
Documents
1
Period of Report
2014-06-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4061214global_cellularbio.html 4  
1 OWNERSHIP DOCUMENT f4061214global_cellularbio.xml 4 3366
  Complete submission text file 0001213900-15-009092.txt   5124
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Issuer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TRINITY CHAMBERS, P.O. BOX 4301 ROAD TOWN TORTOLA D8 00000
Business Address TRINITY CHAMBERS, P.O. BOX 4301 ROAD TOWN TORTOLA D8 00000 (852) 3107-0682
Global Health Investment Holdings Ltd. (Reporting) CIK: 0001569927 (see all company filings)

State of Incorp.: D8
Type: 4 | Act: 34 | File No.: 001-36498 | Film No.: 151255076